KALA BIO, Inc. Common Stock (KALA) is a publicly traded Healthcare sector company. As of July 23, 2026, KALA trades at $0.74 with a market cap of $13.63M and a P/E ratio of -0.23. KALA moved +3.60% today. Year to date, KALA is -97.35%; over the trailing twelve months it is -99.73%. Its 52-week range spans $0.70 to $1,030.00. Rallies surfaces KALA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $0.74 |
| Market Cap | $13.63M |
| P/E Ratio | -0.23 |
| EPS | $-3.31 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,030.00 |
| 52-Week Low | $0.70 |
| Volume | 109.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.98M |
| Gross Margin | 0.00% |
KALA analyst coverage data. Average price target: $0.00.